Menu UF Health Home Menu
 
Morel SA

Drugs for Metabolism Could Reverse Lupus

The study performed by the Morel Laboratory  provides compelling evidence that a combination of metabolic inhibitors could be an effective lupus therapy

Dr. Laurence Morel

A Clear Direction

Dr. Laurance Morel is the Director of the Experimental Pathology division at UF’s College of Medicine

Read More Now
morel-moma1

Select Publications

Lupus resistance is associated with marginal zone abnormalities in an NZM murine model

Read More
House_Lupus3

Sometimes, it’s Lupus

Fictional character Dr. House is famous for proclaiming “It’s not Lupus,” but with 5 million Americans suffering from Lupus, it is certainly not an uncommon disease by an stretch of the imagination.

Read More
Prev Next

Contact Us

Nature ImmunologySubscribe to this RSS Feed

XBP1, a determinant of the eosinophil lineage

July 21, 2015

Targeted deletion of the transcription factor XBP1 in hematopoietic stem cells selectively prevents eosinophil maturation in the bone marrow without affecting other lineages of the immune system.

Tuning up FALCs: immunological shielding in the body cavities

July 21, 2015

Fat-associated lymphoid clusters (FALCs) are non-classical secondary lymphoid organs of the body cavities. The formation and maturation of FALCs are driven by tumor-necrosis factor and are further...

DPP4 in anti-tumor immunity: going beyond the enzyme

July 21, 2015

Effective anti-tumor immune therapy in solid tumors relies on the presence of effector T cells. Inhibition of the dipeptidylpeptidase DPP4 (CD26) enhances chemokine CXCL10–mediated infiltration of...

NLRP3 moonlights in TH2 polarization

July 21, 2015

As the cytosolic guardian for many microbial and sterile inflammatory insults, NLRP3 is best appreciated for its innate immunological role mediating inflammasome activation. Now NLRP3 debuts as a...